NEW YORK (GenomeWeb News) – Decode Genetics disclosed in a filing with the US Securities and Exchange Commission yesterday that it will not make its scheduled Oct. 15 interest payment on its outstanding 3.5 percent convertible notes due 2011.

The cash-strapped firm said that it has to pay the interest within 30 days after the Oct. 15 date, or it will be in default under terms of the indentures securing the notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.